Parathyroid disorders: Difference between revisions
Line 109: | Line 109: | ||
|- | |- | ||
| style="background: #DCDCDC; text-align: center;" | Pseudopseudohypoparathyroidism | | style="background: #DCDCDC; text-align: center;" | Pseudopseudohypoparathyroidism | ||
| style="background: #F5F5F5; text-align: center;" |Normal | |||
| style="background: #F5F5F5; text-align: center;" |Normal | |||
| style="background: #F5F5F5; text-align: center;" |Normal | |||
| style="background: #F5F5F5; text-align: center;" | -- | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" | Pseudohypoparathyroidism type 2 | |||
| style="background: #F5F5F5; text-align: center;" |'''↑''' | | style="background: #F5F5F5; text-align: center;" |'''↑''' | ||
| style="background: #F5F5F5; text-align: center;" |'''↓''' | | style="background: #F5F5F5; text-align: center;" |'''↓''' | ||
| style="background: #F5F5F5; text-align: center;" |'''↑''' | | style="background: #F5F5F5; text-align: center;" |'''↑''' | ||
| style="background: #F5F5F5; | | style="background: #F5F5F5;| | ||
* | *'''↓''' [[1,25-dihydroxy vitamin D|1,25 Dihydroxy vitamin D]] | ||
*Normal [[urinary]] [[cAMP]] | *Normal [[urinary]] [[cAMP]] | ||
*'''↓''' [[Urinary]] [[phosphate]] | *'''↓''' [[Urinary]] [[phosphate]] | ||
|- | |- | ||
| rowspan="2" style="background: #DCDCDC; text-align: center;" |Acrodysostosis | | rowspan="2" style="background: #DCDCDC; text-align: center;" |Acrodysostosis |
Revision as of 17:57, 6 October 2017
Parathyroid disorders |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Synonyms and keywords:
Overview
Classification
Parathyroid disorders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hyperparathyroidism | Familial hypocalciuric hypercalcemia | Hypoparathyroidism | Parathyroid hormone resistance diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Primary | Secondary | Tertiary | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Post-surgical | Autoimmune | Genetic defects associated | Functional | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Pseudohypoparathyroidism | Acrodysostosis | Blomstrand chondrodysplasia | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Pseudohypoparathyroidism type 1 | Pseudohypoparathyroidism type 2 | Acrodysostosis type 1 | Acrodysostosis type 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Type 1A | Type 1B | Type 1C | Pseudopseudohypoparathyroidism | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnosis
Disorder | Laboratory findings | ||||
---|---|---|---|---|---|
Parathyroid hormone | Serum calcium | Serum phosphate | Other findings | ||
Hyperparathyroidism | Primary hyperparathyroidism | ↑ | ↑ | ↓/Normal |
|
Secondary hyperparathyroidism | ↑ | ↓/Normal | ↑ | -- | |
Tertiary hyperparathyroidism | ↑ | ↑ | ↑ | -- | |
Familial hypocalciuric hypercalcemia | Normal/↑ | Normal/↑ | -- |
| |
Hypoparathyroidism | ↓ | ↓ | ↑ |
| |
Pseudohypoparathyroidism | Pseudohypoparathyroidism type 1A | ↑ | ↓ | ↑ | |
Pseudohypoparathyroidism type 1B | ↑ | ↓ | ↑ | ||
Pseudohypoparathyroidism type 1C | ↑ | ↓ | ↑ | ||
Pseudopseudohypoparathyroidism | Normal | Normal | Normal | -- | |
Pseudohypoparathyroidism type 2 | ↑ | ↓ | ↑ |
| |
Acrodysostosis | Acrodysostosis type 1 | ↑ | ↓ | ↑ |
|
Acrodysostosis type 2 | ↑ | ↓ | ↑ |
| |
Blomstrand chondrodysplasia | ↑ | ↓ | ↑ |
Differentiating Parathyroid Disorders
- Parathyroid disorders usually cause an symptoms due to derangement in serum calcium. So, parathyroid disorders are differentiated within themselves and others on the basis of serum calcium levels.
A01=Hypercalcemia
B01=Repeat (Check ionized calcium or Calcium corrected for albumin)
C01=Hypercalcemia confirmed
D01=Measure parathyroid hormone (PTH)
E01=↑ parathyroid hormone|E02=Mildly ↑ parathyroid hormone|E03= ↓ parathyroid hormone
F01=Hyperparathyroidism|F02=Urinary calcium creatinine ratio|F03=Measure parathyroid hormone related peptide (PTHrP) and vitamin D metabolites
G01=↑ serum phosphate
History of renal transplantation|G02=↓/Normal phosphate levels|G03=↑ Urinary calcium creatinine ratio|G04=↓ Urinary calcium creatinine ratio
H01=Tertiary hyperparathyroidism|H02=Primary hyperparathyroidism|H03= Familial hypocalceuric hypercalcemia|
I01=↑ PTHrP|I02=↑ 1,25-dihydroxy vitamin D|I03=↑ 25-hydroxy vitamin D|I04=↓ 1,25-dihydroxy vitamin D|I05=Normal PTHrP and vitamin D metabolites|
J01=Humoral hypercalcemia of malignancy|J02=Chest X-ray, ACE levels|J03=Hypervitaminosis D|J04=History of high milk intake
Excess calcium intake for treating osteoporosis or dyspepsia|J05=Serum protein electrophoresis|J06=Mammography|J07=Check medications
K01=Bilateral hilar lympadenopathy, ↑ ACE levels|K02=Milk-alkali syndrome|K03=Multiple myeloma|K04=Breast cancer
L01=Sarcoidosis|L02=Lithium induced hypercalcemia|L03=Thiazide diuretic induced hypercalcemia